Lab On-Chip And Microarrays Market Share, Outlook, Future Growth and Opportunities 2021-2027

Precision Business Insights published a research report on “Lab On-Chip and Microarrays Market : By Product Type (Lab-On-A-Chips (PDMS Lab-On-A-Chip, Thermo Polymers Lab-On-A-Chip, Glass LAB-ON-A-CHIP, Silicon Lab-On-A-Chip, Paper Lab-On-A-Chip) Microarrays (DNA Microarrays, Tissue Microarrays, Protein Microarray, Others)), By End User (Biotechnology and Pharmaceutical Firms, Academic and Research Institutions, Hospitals and Diagnostic Centres) and Geography - Global/Region/Country Forecast to 2027".

A biochip is a device that combines one or more laboratory operations into a single chip, allowing for high-throughput testing and automation. Nanotechnology advancements have contributed to the growth of lab-on-a-chip technologies. In a few millimeters to a few square centimeters sized device, lab-on-a-chip can incorporate multiple laboratory functions. A biochip device is used to conduct studies on a small scale, allowing for high-throughput automation and screening. Since their introduction in the 1990s, microarrays (biochips) have been the technology of choice for large-scale gene expression studies. RNA-sequencing (RNA-seq) and Next Generation Sequencing have exploded in popularity in recent years, owing to the presence of potential alternative technologies also including RNA-seq and Next Generation Sequencing (NGS). Microarray technique can have limited sensitivity and accuracy. Furthermore, owing to the reduced dynamic range of conventional microarrays, precision may be harmed. Background hybridization reduces the precision of expression measurements, particularly for small transcripts. The hybridization characteristics of probes also differ significantly. Microarrays can only investigate the genes for which probes have been created.

View detailed report description here https://precisionbusinessinsights.com/market-reports/lab-on-chip-and-microarrays-market/

Biochips are becoming more and more popular in biomedical and biotechnological research. The use of biochips in proteomics, also including microarrays, has increased as technology has advanced. Protein biochips have several advantages, including reduced sample consumption and a proclivity for downsizing. Microarray features are crucial for proteome-wide investigation. Proteomics is being increasingly used to develop biomarkers and drugs. Furthermore, there is an increase in demand for personalized medicine, which is adding to the market's development. Other drivers driving the lab-on-a-chip and microarrays (biochip) market include the increasing use of biochips in cancer therapy and diagnostics, need for customized medicine, and significant technological breakthroughs in biochip technology. With the rise in COVID-19, there has been an increase in research, which has bolstered lab on chip demand. For example, University of Alberta Powerhouse researchers have collaborated to build a handheld LOC device for screening COVID-19 antibodies quickly.

The Lab-on-a-chip and Microarrays Market is fragmented on the basis of Type, which is further divided into Microarrays and Lab-on-a-chip. On the basis of Product, the market is categorized into Reagents and Consumables, Instruments and Software and Services. On the basis of Application, the market is segregated into Drug Discovery, Clinical Diagnostics, Genomics and Proteomics, and Other Applications. On the basis of End-User, the market is segmented into Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, and Academic and Research Institutes.

China is also investing heavily in scientific research to understand people's biological make-up, as well as analysis techniques, cutting-edge data collecting, and effective computational power, in order to enable a significant volume of research data in the Asia-Pacific region. The country is also a technological leader, particularly in the lab-on-a-chip-based POC. As a result, the market's dominating growth factor is a growing focus on medical trials, precision medicine, technology advancements, and new drug discovery.

Request sample report https://precisionbusinessinsights.com/request-sample?product_id=18033

Some of the major players working in lab on-chip and microarrays market, which include Affymetrix Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biomerieux SA (France), Beckman Coulter Inc. (U.S.), and CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.) to name a few

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.